Monocytes from COVID-19 patients and post-trauma patients also have decreased CD4 expression, suggesting that the impaired immune response of SCD patients could be related to the immunological dysregulation observed in these disease states [46,47]. This evidence concerns the gene CD4 and COVID-19.